EGFL6 promotes endometrial cancer cell migration and proliferation

CONCLUSIONS: EGFL6 is a marker of poor prognosis endometrial cancers, driving cancer cell proliferation and growth. As such EGFL6 represents a potential therapeutic target in endometrial cancer.PMID:38368816 | DOI:10.1016/j.ygyno.2024.02.016

Source: Gynecologic Oncology - February 18, 2024 Category: Cancer & Oncology Authors: Alison A Garrett Shoumei Bai Sandra Cascio Navneet Gupta Dongli Yang Ronald J Buckanovich Source Type: research